Dr Shira Lakhani is the women for this job
Background Wegovy and Zepbound are both approved for weight loss but started as medications for type 2 diabetes
The fiber-based products have a strong track record for digestive health support, and the GLP-1 Booster and Sugar Craving Suppressant have also received strong responses
Most of these medications are on the critical shortage list and expected to remain there until at least midway through 2024, if not longer
Up to 12mmHg systolic blood pressure reduction is a pretty profound drop in blood pressure especially when the average blood pressure was 127mmHg
Through collective creativity, innovation, and vision, the food science community will continue to lead the way in delivering safe, healthy, and sustainable foods